Latest News Archive
Please select Category, Year, and then Month to display items
07 March 2024
Photo Lunga Luthuli
Prof Francois Strydom, Senior Director at the Centre for Teaching and Learning and Simphiwe Kunene, the first African DREAM scholar and a master’s student from the Faculty of Education.
The University of the Free State (UFS) received recognition for its commitment to student success at the 2024 Achieving the Dream (ATD) conference which celebrated its 20-year anniversary. Simphiwe Kunene, an Education master's student originally from the Qwaqwa campus, was selected to represent South Africa as the first DREAM scholar from Africa as part of the conference.
The Achieving the Dream network of over 300 institutions, which is one of the largest movements in US higher education aims to transform colleges and universities so that students of colour and a lower socio-economic status are supported to earn a degree. The UFS is a leading partner in the Siyaphumelela Network, which has been working for 10 years with ATD to enhance the success of students in South Africa. Prof Francois Strydom, Senior Director at the Centre of Teaching and Learning (CTL), accepted the award on behalf of the institution.
Prof Strydom said that collaboration with the ATD and Siyaphumelela institutions has helped the UFS to develop cutting-edge approaches to “level the playing field” and support Kovsies to earn their undergraduate degrees.
The first African DREAM scholar
Kunene was selected as the first African DREAM scholar from the Siyaphumelela network. To select the DREAM scholar, each Siyaphumelela partner institution nominated one student as a preferred candidate. From the proposed candidates, the DREAM scholar was selected by the South African Institute for Distance Education (Saide) based on the following: demonstrating resilience, academic excellence, and a deep commitment to making a positive difference in universities and personal communities.
He addressed the conference of over 2 000 delegates and shared with them his hopes and dreams. Many members of the South African delegation said Simphiwe did his country proud. He had the following to say about his opportunity to be a DREAM scholar: “Being a DREAM scholar was life changing for me, exposing me to an array of opportunities I never knew were possible and available for me. It was as if, for a moment, the world had stopped to just listen to what I had to say."
The way forward
The UFS will continue its work as a partner of the Siyaphumelela network for the 2024-2026 cycle. The multi-stakeholder project team is focused on enhancing undergraduate students’ time, and to position the UFS as a thought and research leader in the area of student success as part of Vision 130.
UFS to monitor the use of ARV-drugs on pregnant women and children
2004-12-08
The University of the Free State (UFS) is to establish a Pharmacovigilance Centre that will monitor the effects of Anti-Retroviral (ARV) drugs on HIV positive pregnant women and children starting early in the new year.
The UFS is one of only two institutions chosen by the Minister of Health, Dr Manto Tshabalala-Msimang, to establish such an ARV monitoring centre.
The other centre will be based at Medical University of South Africa (MEDUNSA) and will concentrate mainly on monitoring the effects of the drugs on adults.
“The establishment of the UFS’s Pharmaconvigilance Centre forms part of government’s Comprehensive Plan on HIV and AIDS, often termed the roll-out plan for ARV drugs. The centre’s primary responsibility will be to specifically monitor the use of these drugs in pregnant women, and children under the age of 13,” said Prof Andrew Walubo of the UFS’s Department of Pharmacology.
“Although most of the side effects of ARV drugs have been identified in other countries, it has now become critical to identify the side effects amongst the South African population. This is important because many people will be exposed to the drugs within a short time. Our aim is so identify the most common side effects and make recommendations for the prevention thereof. The centre will help in detecting the risk of using anti-retroviral drugs in pregnancy and children, and prevention of adverse drug reactions,” said Prof Walubo.
According to Prof Walubo 12 drugs will be monitored – these drugs will be selected according to the patient’s profile.
The centre will comprise of two components: A pregnancy registry, which will focus on a new-born child up until two months and a pediatric registry, which will focus on children who are born of mothers who used ARV drugs and children using ARV drugs.
According to Prof Walubo, the Pharmaconvigilance Centre will also be responsible for offering relevant technical advice, training and selected research on ARV drugs in these patients.
The centre will be fully sponsored by the national Department of Health. It will be based in the UFS’s Faculty of Health Sciences, Department of Pharmacology, and will be run in collaboration with experts from different departments in the faculty.
Media release
Issued by: Lacea Loader
Media Representative
Tel: (051) 401-2584
Cell: 083 645 2454
E-mail: loaderl.stg@mail.uovs.ac.za
8 December 2004